If you’re interested in other valuable CF medical education, our CF Virtual Roundtable webcast is now available on-demand! Start the activity here: virtual.dkbmed.com
In this program, Peter Mogayzel, Jr., MD, PhD leads a case-based discussion with Patrick Flume, MD and Lisa Saiman, MD on challenges in treating lung infections. Watch as they cover the following topics:
Interactive monograph also available!
The effects of CFTR modifiers on improving lung function in people with cystic fibrosis are well known. But what about their effects on the GI tract that directly affect nutrition?
In this issue, Dr. Michael Wilschanski — Director of Hadassah Hospital’s Pediatric Gastroenterology Unit at Hebrew University in Jerusalem — explains how new findings about CFTR modification can impact clinical practice.
Director, Pediatric Gastroenterology Unit,
Division of Pediatrics
Hadassah Medical Center, Hebrew University
Jerusalem, Israel
Professor of Pediatrics
Director, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, MD
Director, Adult Cystic Fibrosis Program
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
Senior Clinical Nurse
The Johns Hopkins University
Baltimore, MD
0.5 hour Physicians
0.5 contact hour Nurses
Launch date: June 21, 2019
Expiration date: June 20, 2021